Savannah James Launches Reframe Beauty With Help From Howard University
- Peerless Magazine
- May 20
- 2 min read
Savannah James has officially entered the beauty world — and she’s doing it her way. On May 15, 2025, she launched Reframe, a luxury skincare line that took two years to develop, with a unique focus on inclusivity and science-backed results. Instead of just putting her name on a label, James partnered with Howard University’s College of Medicine to clinically test her products on a diverse group of people — something still rare in the skincare space.
The clinical trial included 50 participants ranging in age and skin tone, testing products across the full Fitzpatrick Scale (used in dermatology to classify skin tones). “For the longest time, brands didn’t test on deeper skin tones,” James said. “We wanted to change that.”
At launch, Reframe includes three products:
Pigment Processor Daily Brightening Serum ($115)
Compression Complex Sculpting Day Cream ($95)
Circadian Cream Overnight Collagen Seal ($135)
All three are cruelty-free, vegan, and fragrance-free — and yes, James has been using them on her own skin throughout development. The inspiration behind the line? A moment with her daughter.
“Zhuri told me she wanted to be like me when she grows up,” James shared. “It made me ask myself what kind of example I was setting — what kind of legacy I was building.”
That moment led her to reimagine what clinical skincare could be. Instead of sterile, clinical packaging, Reframe’s bright, museum-inspired design makes a statement — just like James intended.
“I wanted it to feel like something you’d want to leave out on your counter.”
Though Reframe is starting with just three products, James says there’s more on the way. For now, it’s available exclusively on ReframeBeauty.com, but retail partnerships may come down the line. “We’re being strategic. We want to do this right.”
With Reframe, Savannah James isn’t just launching a beauty brand — she’s carving out a more inclusive and intentional space in skincare, and proving that clinical and cultural credibility don’t have to be separate things.
Comments